BioCentury
ARTICLE | Clinical News

Sunshine Biopharma preclinical data

July 18, 2011 7:00 AM UTC

In vitro, Adva-27a was 16 times more effective at killing multidrug resistant human breast cancer cells than etoposide. Adva-27a is a small molecule topoisomerase II (TOP2) inhibitor. ...